|
bioavailability |
7 |
|
fecal enzyme |
7 |
|
gut microbiota |
7 |
|
l. rhamnosus |
7 |
|
soy isoflavone |
7 |
|
isoprostanes |
4 |
|
cholesterol oxidation products |
2 |
|
hete |
2 |
|
hetes |
2 |
|
medaka fish |
2 |
|
neuroprostanes |
2 |
|
oxidative stress |
2 |
|
oxidized lipid products |
2 |
|
polyunsaturated fatty acids |
2 |
|
sonoporation |
2 |
|
1-alkyl-2-acetylglycerophosphocholine esterase - genetics - metabolism |
1 |
|
24-hydroxycholesterol |
1 |
|
8-hydroxy-2′-deoxyguanosine |
1 |
|
adrenic acid |
1 |
|
adult |
1 |
|
aged |
1 |
|
allantoin |
1 |
|
allantoin - blood |
1 |
|
alpha‐linolenic acid |
1 |
|
antioxidant |
1 |
|
atherosclerosis |
1 |
|
bioactive |
1 |
|
bioactive lipid mediators |
1 |
|
biological markers - blood - urine |
1 |
|
biological markers - metabolism |
1 |
|
biomarker |
1 |
|
blood pressure |
1 |
|
c-reactive protein - chemistry |
1 |
|
c-reactive protein - genetics - metabolism |
1 |
|
camelina sativa oil |
1 |
|
cardiac arrhythmias |
1 |
|
case-control studies |
1 |
|
cerebral function |
1 |
|
cholesterol - analogs & derivatives - blood - urine |
1 |
|
cholesterol - blood |
1 |
|
cholesterol - chemistry |
1 |
|
cigarette smoking |
1 |
|
dengue |
1 |
|
dengue - blood - genetics - physiopathology |
1 |
|
dengue virus - pathogenicity - physiology |
1 |
|
diabetes mellitus, type 2 - blood - drug therapy - physiopathology |
1 |
|
dietary supplements |
1 |
|
disease progression |
1 |
|
dna - chemistry |
1 |
|
f 2-isoprostanes |
1 |
|
f2-isoprostanes |
1 |
|
f2-isoprostanes - blood - metabolism - urine |
1 |
|
f2-isoprostanes - blood - urine |
1 |
|
f2-isoprostanes - chemistry |
1 |
|
f4-neuroprostanes |
1 |
|
fatty acid |
1 |
|
feed intake |
1 |
|
female |
1 |
|
fish |
1 |
|
free radicals |
1 |
|
gc-ms |
1 |
|
gene expression regulation |
1 |
|
humans |
1 |
|
hydroxycholesterols - blood - metabolism |
1 |
|
hydroxyeicosatetraenoic acid products |
1 |
|
hydroxyeicosatetraenoic acids - blood - metabolism - urine |
1 |
|
hydroxyeicosatetraenoic acids - blood - urine |
1 |
|
hydroxyeicosatetraenoic acids - chemistry |
1 |
|
impaired glucose tolerance |
1 |
|
isoprostanoids |
1 |
|
krabbe disease |
1 |
|
lc-ms/ms |
1 |
|
leukodystrophy |
1 |
|
levodopa - pharmacology |
1 |
|
lipid peroxidation |
1 |
|
lipidomics |
1 |
|
lipids - chemistry |
1 |
|
male |
1 |
|
mecp2 mutation |
1 |
|
middle aged |
1 |
|
murine models |
1 |
|
natural history |
1 |
|
neurological disease |
1 |
|
omega 3 pufas |
1 |
|
oxidative damage |
1 |
|
oxidative stress - drug effects |
1 |
|
oxygen - chemistry |
1 |
|
oxysterols |
1 |
|
parkinson disease |
1 |
|
parkinson disease - blood - diagnosis - pathology |
1 |
|
phenotype |
1 |
|
platelet dysfunction |
1 |
|
platelet function |
1 |
|
pufas |
1 |
|
rainbow trout |
1 |
|
redox homeostasis |
1 |
|
redox pathologies |
1 |
|
redox signaling |
1 |
|
rett syndrome |
1 |
|
ros |
1 |
|
smoking - blood - metabolism - urine |
1 |
|
tumor necrosis factor-alpha - genetics - metabolism |
1 |
|
type 2 diabetes |
1 |
|
vascular disease |
1 |
|
vascular function |
1 |
|
virulence |
1 |
|
zinc |
1 |
|
zinc - administration and dosage - blood |
1 |
|
ω-3 long chain polyunsaturated fatty acid |
1 |
